MEDBOT-B Shares Surge Over 5% as Global Commercial Installations of Toumai Exceed 200 Units

Stock News

06/29

The stock of MEDBOT-B (02252) has risen more than 5%. As of writing, it is up 4.95% to HK$22.88, with a turnover of HK$26.08 million.

The company has announced a significant milestone. Following the achievement of over 300 global commercial orders for its core product, the Toumai endoscopic surgery robot, the system has now been installed at the 200th commercial site worldwide. This latest installation took place at the prestigious Spanish medical institution, HM Hospitales. All 200 installed units have received formal acceptance reports from the end customers.

Market Leadership Position

According to publicly available market statistics, the Toumai robot has achieved the highest number of new global commercial installations among domestic Chinese products so far this year. Globally, it ranks within the top two for this metric.

Significance of the Milestone

The company stated that surpassing these dual milestones in commercial orders and installations signifies the accelerating maturity of Toumai's global clinical ecosystem, real-world application framework, and remote collaboration network.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1170620072"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1170620072\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1170620072?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-29 10:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170620072","market":"us","top_or_hot":-1,"title":"MEDBOT-B Shares Surge Over 5% as Global Commercial Installations of Toumai Exceed 200 Units","media":"Stock News","content":"<p>The stock of <b>MEDBOT-B</b> (<b>02252</b>) has risen more than 5%. As of writing, it is up 4.95% to HK$22.88, with a turnover of HK$26.08 million.<br><br>\nThe company has announced a significant milestone. Following the achievement of over 300 global commercial orders for its core product, the Toumai endoscopic surgery robot, the system has now been installed at the 200th commercial site worldwide. This latest installation took place at the prestigious Spanish medical institution, HM Hospitales. All 200 installed units have received formal acceptance reports from the end customers.<br><br>\n<b>Market Leadership Position</b><br><br>\nAccording to publicly available market statistics, the Toumai robot has achieved the highest number of new global commercial installations among domestic Chinese products so far this year. Globally, it ranks within the top two for this metric.<br><br>\n<b>Significance of the Milestone</b><br><br>\nThe company stated that surpassing these dual milestones in commercial orders and installations signifies the accelerating maturity of Toumai's global clinical ecosystem, real-world application framework, and remote collaboration network.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MEDBOT-B Shares Surge Over 5% as Global Commercial Installations of Toumai Exceed 200 Units</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMEDBOT-B Shares Surge Over 5% as Global Commercial Installations of Toumai Exceed 200 Units\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-06-29 10:18</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>The stock of <b>MEDBOT-B</b> (<b>02252</b>) has risen more than 5%. As of writing, it is up 4.95% to HK$22.88, with a turnover of HK$26.08 million.<br><br>\nThe company has announced a significant milestone. Following the achievement of over 300 global commercial orders for its core product, the Toumai endoscopic surgery robot, the system has now been installed at the 200th commercial site worldwide. This latest installation took place at the prestigious Spanish medical institution, HM Hospitales. All 200 installed units have received formal acceptance reports from the end customers.<br><br>\n<b>Market Leadership Position</b><br><br>\nAccording to publicly available market statistics, the Toumai robot has achieved the highest number of new global commercial installations among domestic Chinese products so far this year. Globally, it ranks within the top two for this metric.<br><br>\n<b>Significance of the Milestone</b><br><br>\nThe company stated that surpassing these dual milestones in commercial orders and installations signifies the accelerating maturity of Toumai's global clinical ecosystem, real-world application framework, and remote collaboration network.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1617","symbol_name":"AI醫療","start_time":0,"source_url":"","article_id":"1170620072","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170620072","pubTimestamp":1782699514,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"The stock of MEDBOT-B (02252) has risen more than 5%. As of writing, it is up 4.95% to HK$22.88, with a turnover of HK$26.08 million. The company has announced a significant milestone. Following the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1617":"AI医疗","VXUS":"国际股票ETF-Vanguard","BK4588":"碎股","02252":"微创机器人-B","BK1100":"医疗保健设备","BK4585":"ETF&股票定投概念"},"translate_title":"图迈全球商业安装量突破200台，MEDBOT-B股价飙升逾5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":1,"VXUS":1},"content_text":"The stock of MEDBOT-B (02252) has risen more than 5%. As of writing, it is up 4.95% to HK$22.88, with a turnover of HK$26.08 million.\nThe company has announced a significant milestone. Following the achievement of over 300 global commercial orders for its core product, the Toumai endoscopic surgery robot, the system has now been installed at the 200th commercial site worldwide. This latest installation took place at the prestigious Spanish medical institution, HM Hospitales. All 200 installed units have received formal acceptance reports from the end customers.\nMarket Leadership Position\nAccording to publicly available market statistics, the Toumai robot has achieved the highest number of new global commercial installations among domestic Chinese products so far this year. Globally, it ranks within the top two for this metric.\nSignificance of the Milestone\nThe company stated that surpassing these dual milestones in commercial orders and installations signifies the accelerating maturity of Toumai's global clinical ecosystem, real-world application framework, and remote collaboration network.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}